Earlier this week in an opinion piece for the New York Times filmmaker, Angelina Jolie Pitt describes her decision to have her ovaries and fallopian tubes removed. The surgery comes just two years after her choice to have a double mastectomy. Genetic tests had confirmed she carried a mutation in the BRCA gene which put her at greater risk for breast and ovarian cancer. Many doctors say her decision was a good one, but it highlights the kinds of challenges genetic test results can present: Please join us to discuss BRCA test results and efforts to stop breast and ovarian cancers before they start.


  • Mary-Claire King Professor of medicine and genome sciences, University of Washington.
  • Beth Peshkin Senior genetics counselor, Lombardi Comprehensive Cancer Center and professor of oncology,Georgetown University Medical Center.
  • Dr Amanda Nickles Fader Director, Kelly Gynecologic Oncology Service, associate professor of gynecology and obstetrics, Johns Hopkins Medicine.

Topics + Tags


comments powered by Disqus
Most Recent Shows

Revisiting The Decision To Drop The Bomb

Thursday, May 18 2023As President Biden's visit to Hiroshima dredges up memories of World War II, Diane talks to historian Evan Thomas about his new book, "Road to Surrender," the story of America's decision to drop the atomic bomb.